Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Caspase
    (1)
  • GABA Receptor
    (1)
  • GNRH Receptor
    (1)
  • Lipid
    (1)
  • MicroRNA
    (1)
  • Others
    (4)
TargetMol | Tags By ResearchField
  • Cancer
    (3)
  • Nervous System
    (2)
  • Cardiovascular System
    (1)
  • Inflammation
    (1)
Filter
Search Result
Results for "

T2783

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    6
    TargetMol | All_Pathways
  • Natural Products
    2
    TargetMol | Natural_Products
Methyl dihydrojasmonate
Methyl Dihydrojasmonate, Kharismal, Hedione
T278324851-98-7
Methyl dihydrojasmonate (Kharismal) is an ester and a diffusive aroma compound, with the smell vaguely similar to jasmine. In racemic mixtures the odor is floral and citrus while epimerized mixtures exhibit a dense fatty floral odor with odor recognition thresholds of 15 parts per billion.
  • $50
Inquiry
Size
QTY
Lifibrol
U-83860, U 83860, K-12148, K12148, K-12.148
T2783296609-16-4In house
Lifibrol (U-83860) is an inhibitor of cholesterol synthesis.Lifibrol has anticholesterol and hypolipidemic properties and promotes the conversion of LDL Apo B-100 in patients with hypercholesterolemia and mixed hyperlipidemia.
  • $53
In Stock
Size
QTY
Lirequinil
RO41-3696, Ro-41-3696, RO-413696, RO413696, Ro 41-3696, RO 413696
T27838143943-73-1In house
Lirequinil (Ro 41-3696) is a small molecule GABAA receptor agonist utilized in the study of neurological disorders.
  • $160
In Stock
Size
QTY
Lin281632
Lin-281632, Lin-28 1632, Lin28 1632, Lin 281632, Lin 28 163
T27835108825-65-6
Lin28 1632 is an inhibitor of RNA binding protein Lin28. It promotes mESC differentiation. Lin281632 is also bromodomain inhibitor.
  • $30
In Stock
Size
QTY
Limonin glucoside
CCRIS-6986, CCRIS6986, CCRIS 6986
T27834123564-61-4
Limonin glucoside is a natural product in citrus fruits. It inhibits expression of HIV-1 and HTLV-1 in infected cells, induces apoptosis in colon adenocarcinoma cells, and exhibits larvicidal activity against species of Aedes.
  • $765
35 days
Size
QTY
Linzagolix
T27837935283-04-8
Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by Kissei Pharmaceutical and ObsEva for the treatment of uterine fibroids, endometriosis, and adenomyosis. As of December 2020, it is under review for approval for uterine fibroids, is in phase III clinical trials for endometriosis, and is in phase II clinical studies for adenomyosis.
  • $35
In Stock
Size
QTY